Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and Stroke

Background— Prediction of stroke and atrial fibrillation in healthy individuals is challenging. We examined whether excessive supraventricular ectopic activity (ESVEA) correlates with risk of stroke, death, and atrial fibrillation in subjects without previous stroke or heart disease. Methods and Results— The population-based cohort of the Copenhagen Holter Study, consisting of 678 healthy men and women aged between 55 and 75 years with no history of cardiovascular disease, atrial fibrillation, or stroke, was evaluated. All had fasting laboratory tests and 48-hour ambulatory ECG monitoring. ESVEA was defined as ≥30 supraventricular ectopic complexes (SVEC) per hour or as any episodes with runs of ≥20 SVEC. The primary end point was stroke or death, and the secondary end points were total mortality, stroke, and admissions for atrial fibrillation. Median follow-up was 6.3 years. Seventy subjects had SVEC ≥30/h, and 42 had runs of SVEC with a length of ≥20 SVEC. Together, 99 subjects (14.6%) had ESVEA. The risk of primary end point (death or stroke) was significantly higher in subjects with ESVEA compared with those without ESVEA after adjustment for conventional risk factors (hazard ratio=1.64; 95% confidence interval, 1.03 to 2.60; P=0.036). ESVEA was also associated with admissions for atrial fibrillation (hazard ratio=2.78; 95% confidence interval, 1.08 to 6.99; P=0.033) and stroke (hazard ratio=2.79; 95% confidence interval, 1.23 to 6.30; P=0.014). SVEC, as a continuous variable, was also associated with both the primary end point of stroke or death and admissions for atrial fibrillation. Conclusions— ESVEA in apparently healthy subjects is associated with development of atrial fibrillation and is associated with a poor prognosis in term of death or stroke.

[1]  D. Levy,et al.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.

[2]  L. Caplan.  Cerebrovascular diseases. , 2008, Reviews in neurological diseases.

[3]  H. Mattle,et al.  Frequent Atrial Premature Beats Predict Paroxysmal Atrial Fibrillation in Stroke Patients: An Opportunity for a New Diagnostic Strategy , 2007, Stroke.

[4]  Sverker Jern,et al.  Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. , 2006, JAMA.

[5]  S. Sacco,et al.  Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study , 2005, Stroke.

[6]  H. Hein,et al.  Prevalence and prognostic significance of daily-life silent myocardial ischaemia in middle-aged and elderly subjects with no apparent heart disease. , 2005, European heart journal.

[7]  M. Nieminen,et al.  Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.

[8]  G. Boysen,et al.  Insular lesions, ECG abnormalities, and outcome in acute stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  B. Stegmayr,et al.  [Improved survival after stroke but unchanged risk of incidence]. , 2003, Läkartidningen.

[10]  N. Kucher,et al.  Frequent atrial premature contractions as a surrogate marker for paroxysmal atrial fibrillation in patients with acute ischaemic stroke , 2003, Heart.

[11]  A. Minagar,et al.  Cardioembolic Stroke: An Update , 2003, Southern medical journal.

[12]  L. Caplan.  Now is an exciting time to care for stroke patients. , 2003, Southern medical journal.

[13]  L. Weisberg,et al.  Treatment of Chronic Hypertension for the Prevention of Stroke , 2003, Southern medical journal (Birmingham, Ala. Print).

[14]  V. Feigin,et al.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century , 2003, The Lancet Neurology.

[15]  S. Straus,et al.  New evidence for stroke prevention: scientific review. , 2002, JAMA.

[16]  D. L. Freeman,et al.  Harrison's Principles of Internal Medicine , 2001 .

[17]  B. Hedblad,et al.  Cardiac Arrhythmias and Stroke: Increased Risk in Men With High Frequency of Atrial Ectopic Beats , 2000, Stroke.

[18]  T. Ingall.  Preventing ischemic stroke , 2000, Postgraduate medicine.

[19]  R. Kronmal,et al.  Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. , 2000, Archives of neurology.

[20]  M. Kapral,et al.  Use of Ambulatory Electrocardiography for the Detection of Paroxysmal Atrial Fibrillation in Patients with Stroke , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[21]  J. Halperin,et al.  Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. , 2000, Journal of the American College of Cardiology.

[22]  J. Caro,et al.  Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[23]  V. Rasmussen,et al.  Prognostic implications of ventricular ectopy one week, one month, and sixteen months after an acute myocardial infarction , 1998 .

[24]  J Nyboe,et al.  Stroke incidence and risk factors for stroke in Copenhagen, Denmark. , 1988, Stroke.

[25]  J. Bigby.  Harrison's Principles of Internal Medicine , 1988 .

[26]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .